The effect of the PD-related pathological mutation (LRRK2G2019S) in the kinase activity has been extensively studied, and it is known that LRRK2 mutations result in increased kinase activity that induces a neurotoxic effect [56]. The gene discussed is LRRK2; the disease is Parkinson disease.